Related Experiment Video
Updated: Jun 29, 2026
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
The role of metastasis suppressor genes in metastatic dormancy
Christine E Horak1, Jong Heun Lee, Jean-Claude Marshall
1Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. horakc@mail.nih.gov
Abstract:
Metastasis suppressor genes (MSGs) are defined by their ability to inhibit overt metastasis in a secondary organ without affecting tumor growth at the primary site. Over 20 MSGs have been confirmed in vivo. This class of genes is only unified by their capacity to suppress metastasis, as they encode for proteins with a wide range of biochemical activities that are components of a variety of signaling pathways. In addition, metastasis suppressors impinge upon different stages of the metastatic cascade to manifest their suppressive effects. The MSGs KISS1, KAI1, MKK4/7 and Nm23-H1 promote tumor dormancy at the metastatic site, since tumor cells with induced expression of these MSGs disseminate, but do not form overt metastases in the secondary organ throughout the duration of a metastasis assay. Evidence suggests that KISS1 triggers dormancy in solitary, metastatic tumor cells by causing growth arrest of solitary cells at the secondary site. KAI1 induces growth arrest prior to extravasation by binding a vascular endothelial cell surface marker. MKK4, MKK7 and Nm23-H1 appear to promote dormancy of micrometastatic colonies, after disseminated tumor cells have undergone several rounds of proliferation. Other MSGs may also function in tumor dormancy, but so far their role has not been fully elucidated. Therapeutic approaches that either mimic the effects of MSGs or re-establish MSG expression in metastatic lesions may hold promise for the establishment or maintenance of dormancy.
Insights
Metastasis suppressor genes (MSGs) inhibit cancer spread to secondary organs. These genes promote tumor dormancy, offering potential therapeutic strategies for managing metastatic disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastasis suppressor genes (MSGs) are critical regulators of cancer cell dissemination and secondary tumor formation.
- Over 20 MSGs have been identified, yet they lack a unified biochemical function, differing in signaling pathways and metastatic cascade stages targeted.
- MSGs are characterized by their ability to inhibit metastasis without impacting primary tumor growth.
Purpose of the Study:
- To elucidate the diverse mechanisms by which metastasis suppressor genes (MSGs) inhibit cancer metastasis.
- To highlight the role of specific MSGs, including KISS1, KAI1, MKK4/7, and Nm23-H1, in promoting tumor dormancy.
- To explore the potential of therapeutic strategies targeting MSGs for cancer treatment.
Main Methods:
- In vivo confirmation of over 20 metastasis suppressor genes (MSGs).
- Analysis of gene expression and protein function in relation to the metastatic cascade.
- Investigation of specific MSGs (KISS1, KAI1, MKK4/7, Nm23-H1) and their roles in tumor dormancy.
Main Results:
- MSGs inhibit metastasis by promoting tumor dormancy at secondary sites.
- KISS1 induces dormancy in solitary tumor cells via growth arrest.
- KAI1 mediates growth arrest before extravasation by interacting with vascular endothelial cells.
- MKK4, MKK7, and Nm23-H1 promote dormancy in micrometastatic colonies after initial proliferation.
Conclusions:
- Metastasis suppressor genes (MSGs) represent a crucial class of anti-metastatic factors.
- Targeting MSGs or mimicking their function offers promising therapeutic avenues for controlling metastatic disease and maintaining tumor dormancy.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...